EVERSANA™ announces an agreement to acquire Cornerstone Research Group; adds global HEOR capabilities to integrated commercial services platform

October 30, 2019

CHICAGO  – October 30, 2019  – EVERSANA™, the leading independent provider of commercial services to the life science industry, today announced an agreement to acquire…

Read More


October 1, 2019

We are currently seeking candidates with an undergraduate or graduate Science degree (Health Sciences, Pharmacology, Epidemiology etc.) with strong analytical and/or writing skills to conduct…

Read More

Burden of Osteoporosis Set to Reach $6.25 Billion Over Five Years Across Four Latin America Countries

June 7, 2019

Over the next five years, ~ 4.5 million fractures are anticipated to occur in Brazil, Mexico, Colombia, and Argentina LONDON-April 24, 2019The financial cost required…

Read More

CORNERSTONE Insights: Beyond the Clinical Trial – Saving Time and Costs by supporting FDA applications with Real-World Evidence

April 3, 2019

By Nicole Ferko, Senior Director The use of Real-World Evidence (RWE) has been rapidly expanding in recent years and has become an integral component to…

Read More

CORNERSTONE Insights: How the Inclusion of Cost-Effectiveness Thresholds in the Management of U.S. Formularies Could Impact Manufacturers

January 22, 2019

By Dan Moldaver In mid-August, CVS Caremark, one of the largest pharmacy benefit managers (PBMs) in the U.S., published a whitepaper that describes a series…

Read More
  • Page 1 of 2
  • 1 2
Copyright © 2020. All Rights Reserved. Cornerstone Research Group